HUM
$414.85-0.57%
as of close, Oct 27, 2026
☾ AH $414.85 -0.57%
HUM — Humana Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDE
200.0250.0300.0350.0400.0450.0500.0550.0020.0M40.0M$414.85—20162019202120242026
2026-10-27
Price$414.85
MA20$382.35
MA50$296.93
Vol5.0M
Key stats#
Price data
- Price
- $414.85
- YTD price return
- +61.97%
- YTD total return
- +63.18%
- Next earnings
- Nov 6, 2026 · Before open
- Market cap
- 49.8B
- Enterprise value
- 40.8B
- Shares outstanding
- 120.1M
- 52W low
- $163.11
- 52W high
- $456.50
- From 52W high
- -9.12%
- From 52W low
- +154.34%
- 52W range
- 86%
- Beta
- 0.73
Volume
- Rel volume
- 0.45×
- 30D volume
- 1.5M
- 30D $ vol
- 614.6M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- +$150K
Form 4 transactions by trade date, as filed; latest on file 2026-02-23.
Fundamentals
- Sales (ttm)
- 145.7B
- Sales/share
- $1,213.18
- EPS (ttm)
- $10.58
- FCF (ttm)
- 1.9B
- FCF/share
- $16.23
- Book value/share
- $160.00
- Net margin
- 0.88%
- ROE
- 6.66%
- ROA
- 2.24%
- Debt / equity
- 0.62×
- Current ratio
- 1.74
Growth (CAGR, ttm) · 10Y
- Sales
- +18.35%+13.84%+12.61%+10.33%
- Net income
- -18.86%-27.65%-12.42%+2.70%
- FCF
- -20.10%-45.64%+33.72%+6.33%
- Shares
- -0.16%-1.04%-1.35%-2.14%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -18.92%-26.62%-10.96%+4.99%
- Sales/share
- +18.53%+15.04%+14.15%+12.74%
- FCF/share
- -19.97%-45.07%+35.54%+8.66%
- Book value/share
- +5.54%+5.60%+6.74%+8.17%
- Dividend/share
- +0.00%+2.11%+6.00%+11.80%
- Price
- +41.94%-6.66%-1.99%+9.04%
- Total return
- +43.49%-5.58%-1.04%+9.94%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 39.2×
- P/OI (ttm)
- 18.4×
- Fwd P/E
- 24.7×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 2.6×
- P/FCF (ttm)
- 25.6×
- EV/EBITDA (fy)
- 11.7×
- EV/Sales (ttm)
- 0.3×
- FCF yield (ttm)
- 3.91%
- Dividend yield (fwd)
- 0.85%
- Dividend yield (ttm)
- 0.85%
- Dividend/share (fwd)
- $3.54
- Buyback yield (realized, 1y)
- 0.16%
- Shareholder yield (realized, 1y)
- 1.62%
- Buyback yield (cash, ttm)
- 0.30%
- Shareholder yield (cash, ttm)
- 1.16%
Vs own 10Y history
- P/E
- 97th
- P/OI
- 93rd
- P/S
- 21st
- P/B
- 24th
- P/FCF
- 80th
Bar = where today’s multiple sits in HUM’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-0.57%
5D
-2.93%
1M
+4.25%
3M
+8.84%
YTD
+61.97%
1Y
+41.91%
5Y
-9.55%
Recent filings#
- Oct 138-K · Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
- Jul 29Earnings · Earnings release — EPS $7.61 vs $6.22 est. (+22.4%); revenue $40.87B (+26% y/y) 6.0%
- Jul 298-K · Humana Elects Paul Smith and Frederick Crawford to Board of Directors
Financial statements
Open full HUM financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
